Experience with cyclosporine.

Sandrini, S; Setti, G; Bossini, N; Zubani, R; Cassamali, S; Maiorca, P; Maffeis, R; Portolani, N; Bonardelli, S; Nodari, F; Tardanico, R; Corbetta, G; Cancarini, G

Sandrini, S; Setti, G; Bossini, N; Zubani, R; Cassamali, S; Maiorca, P; Maffeis, R; Portolani, N; Bonardelli, S; Nodari, F; Tardanico, R; Corbetta, G; Cancarini, G.

Affiliation

Sandrini S; Department of Nephrology, University of Brescia and Spedali Civili, Brescia, Italy. sandrini.silvio@libero.it

Transplant Proc ; 36(2 Suppl): 152S-157S, 2004 Mar.

Article in En | MEDLINE | ID: mdl-15041327

Subject(s)

Cyclosporine/therapeutic use; Graft Survival/immunology; Kidney Transplantation/physiology; Cadaver; Graft Survival/drug effects; Humans; Immunosuppressive Agents/therapeutic use; Kidney Transplantation/immunology; Kidney Transplantation/mortality; Living Donors; Survival Analysis; Time Factors; Tissue Donors/statistics & numerical data

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Cyclosporine / Graft Survival Limits: Humans Language: En Journal: Transplant Proc Year: 2004 Document type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links